Marc Wilson - 31 Dec 2022 Form 5 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
CFO
Signature
/s/ Marc Wilson
Issuer symbol
CRNX
Transactions as of
31 Dec 2022
Transactions value $
$21,247
Form type
5
Filing time
27 Jan 2023, 15:29:02 UTC
Previous filing
02 Mar 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Other $15.9K +1.45K +1.77% $11.02 83.1K 20 May 2022 Direct F1
transaction CRNX Common Stock Other $5.31K +482 +0.58% $11.02 83.5K 20 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),